Cedazuridine

Chemical Information
Myelodysplastic syndromes (MDS) are a group of hematopoietic neoplasms that give rise to variable cytopenias progressing to secondary acute myeloid leukemia (sAML), which is invariably fatal if untreated. Hypomethylating agents such as [decitabine] and [azacitidine] are used to treat MDS through inducing DNA hypomethylation and apoptosis of cancerous cells. Although effective, these compounds are rapidly metabolized by cytidine deaminase (CDA) prior to reaching systemic circulation when administered orally, necessitating intramuscular or intravenous administration routes. Cedazuridine is a fluorinated tetrahydrouridine derivative specifically designed to inhibit CDA and facilitate oral administration of hypomethylating agents. Cedazuridine was first reported in 2014, and was subsequently approved by the FDA on July 7, 2020, in combination with [decitabine] for sale by Astex Pharmaceuticals Inc under the name INQOVI®.
| CAS Number | 1141397-80-9 |
| PubChem CID | 25267009 |
| IUPAC Name | (4R)-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydroxy-1,3-diazinan-2-one |
| Molecular Formula | C9H14F2N2O5 |
| Molecular Weight | 268.21 |
| XLogP | -1.1 |
| Topological Polar Surface Area | 102 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 2 |
| Heavy Atom Count | 18 |
| Formal Charge | 0 |
| Complexity | 343 |
| Property | Value |
|---|---|
| Molecular Weight | 268.21 |
| XLogP3 | -1.1 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 2 |
| Exact Mass | 268.08707788 |
| Monoisotopic Mass | 268.08707788 |
| Topological Polar Surface Area | 102 Ų |
| Heavy Atom Count | 18 |
| Formal Charge | 0 |
| Complexity | 343 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently-Bonded Unit Count | 1 |
| Compound Is Canonicalized | Yes |
Alternative Products
Popular Products

Anti-LRRK2/Dardarin Antibody
SKU: 56563|Size: 1 Each

MFNG Peptide
SKU: GTR19054825|Size: 100 µg

Anti-LRRK2/Dardarin Antibody (1D8)
SKU: MBS1571627-01|Size: 0.1 mg

Optiprep
SKU: 1893-01|Size: 250 mL

Carbonate-Bicarbonate Buffer Packs
SKU: 40220092-1|Size: 40 PKS

EGTA/AM (EGTA Acetoxymethyl ester)
SKU: 448101|Size: 10 mg

Fluo-4 AM
SKU: HY-101896-01|Size: 100 µg

Fetal Bovine Serum, Premium, US Origin
SKU: F0600-050|Size: 500 mL

Plant Preservative Mixture (PPM)
SKU: P5550-01|Size: 25 mL

Native Glycated Hemoglobin A1c (HbA1c) recombinant protein
SKU: TRV-035357|Size: 1 mg

PSNAPf Vector
SKU: NEB N9183S|Size: 20 µg

Strips of 8 Flat Optical Caps, 300 strips per case
SKU: 4TI-0751|Size: 300 Strips

NEBNext End Repair Module
SKU: E6050S|Size: 20 Assays

NEBNext Quick Ligation Module
SKU: E6056S|Size: 20 Assays

NEBNext Ultra II nn-Directional RNA Second Strand Module
SKU: E6111L|Size: 100 Assays

NEBNext Ultra II nn-Directional RNA Second Strand Module
SKU: E6111S|Size: 20 Assays

NEBNext Fast DNA Library Prep Set for Ion Torrent
SKU: E6270L|Size: 50 Assays

NEBNext Multiplex Oligos for Illumina Set 1 (96 Unique Dual Index Primer Pairs)
SKU: E6440S|Size: 96 Reactions

NEBNext Multiplex Oligos for Illumina Set 2 (96 Unique Dual Index Primer Pairs)
SKU: E6442S|Size: 96 Reactions

NEBNext Multiplex Oligos for Illumina Set 3 (96 Unique Dual Index Primer Pairs)
SKU: E6444S|Size: 96 Reactions
